Latest Breaking News On - Wakefulness test - Page 1 : comparemela.com

TAK-861 Shows Promise in Phase 2b Narcolepsy Type 1 Trial

TAK-861 demonstrated significant and sustained improvements in the treatment of narcolepsy type 1 in a phase 2b clinical trial.

Drug administrationBreakthrough therapyNarcolepsy typeWakefulness testEpworth sleepiness scaleWeekly cataplexy rateToward phase

Alkermes to Present Data for ALKS 2680 in Narcolepsy Treatment

Alkermes will present new data for its investigational narcolepsy treatment, ALKS 2680, at SLEEP 2024 in Houston.

United statesCraig hopkinsonMichaelj doaneRon grunsteinDavidt planteUniversity of wisconsinWoolcock institute of medical researchStudy dataWakefulness testKarolinska sleepiness scaleWoolcock instituteAssociate professor

Alkermes plc: Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024

- Late-Breaking Abstracts Containing Data From the Full Narcolepsy Type 1 Cohort From the ALKS 2680 Phase 1b Study and Vibrance-1 Phase 2 Study Design Accepted for Poster Presentations - -

United statesCraig hopkinsonGretchen murphyMichaelj doaneDavidt planteRon grunsteinSandy coombsUniversity of wisconsinGroup study evaluating the safetyResearch development at alkermesWoolcock institute of medical researchWorld sleep congressCircadian researchBreaking abstracts containing data fromFull narcolepsy typeDesign accepted

Takeda Pharmaceutical : FY2023 (April 2023-March 2024) Quarter 4 Quarterly Financial Report

Takeda Pharmaceutical : FY2023 (April 2023-March 2024) Quarter 4 Quarterly Financial Report
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoUnited kingdomKendall squareShonan health innovation parkGreater boston area researchAmerican society of clinical oncologyNational medical products administrationDevelopment siteAustria researchJapanese ministry of healthMinistry of healthInternational society on thrombosisEuropean medicines agencyActual exchange rateCommittee for medicinal products human use

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

BOSTON and LONDON, April 22, 2024 Centessa Pharmaceuticals plc , a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today.

City ofUnited kingdomUnited statesKristenk sheppardExchange commissionCentessa pharmaceuticalsDrug administrationInvestigational new drugWakefulness testKarolinska sleepiness scaleSaurabh sahaChief executive officerAnnual reportQuarterly reportsInvestor relations